People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nautilus Neurosciences, Inc. | — | Pharmaceuticals | Series B | $53.3M | $272.0M | 2009 |
James L. Fares at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James L. Fares on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Geoffrey S. Raker | 1 | 6 |
| Frank V Sica | 1 | 3 |
| Douglas M. Karp | 1 | 2 |
| Neil R. Milano | 1 | 1 |
| William V. Maichle | 1 | 1 |
| David V. Azad | 1 | 1 |
| Zubeen V. Shroff | 1 | 1 |
| John V. Groom | 1 | 1 |
| Eric J. Liebler | 1 | 1 |
| William R. Maichle | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.